Novo Nordisk CEO Lars Fruergaard Jorgensen discusses earnings as well as the competitive landscape in the pharmaceutical sector. He speaks with Bloomberg's Katie Greifeld and Alix Steel.

Senior Fellow at Council on Foreign Relations Rebecca Patterson Talks "Too Much"
07:54

Chief Economist at New Century Advisors Claudia Sahm Talks Labor Market
08:57

NEC Director Kevin Hassett Talks US Debt
09:38